Life Scientist > Biotechnology

An alternative to antibiotics for CF patients

15 March, 2017

UK scientists have shown that bacteriophage (phage) therapy could offer a safe and effective alternative to antibiotics in the treatment of cystic fibrosis (CF) lung infections.


Pest rabbits succumbing to Korean calicivirus

14 March, 2017

CSIRO scientists have confirmed the first pest rabbit that has succumbed to the Korean strain of calicivirus, known as RHDV1 K5.


Tackling tuberculosis with garden dirt

02 March, 2017 by Adam Florance

Tuberculosis may seem like a disease of yesteryear, but new drug-resistant strains of Mycobacterium tuberculosis are on the rise.


3D-printed sternum successfully implanted

28 February, 2017

A collaboration between CSIRO, Anatomics and British doctors has resulted in the world's first implementation of a 3D-printed titanium and polymer sternum into a patient.


Medicinal cannabis access fast-tracked for Australian patients

22 February, 2017 by Lauren Davis

The Turbull government will facilitate faster access by qualified doctors to medicinal cannabis for approved patients.


Alzheimer's drug trial abandoned due to lack of efficacy

16 February, 2017 by Lauren Davis

Pharmaceutical company MSD has ended its phase 2/3 study evaluating the drug verubecestat in patients with mild to moderate forms of Alzheimer's disease (AD).


Breakthrough in treating diabetic kidney disease

13 February, 2017

Researchers have prevented the progression of diabetic kidney disease (DKD) in laboratory studies of type 2 diabetes, signalling an important breakthrough in the field of diabetes research.


Ebola treatment developed from horse antibodies

08 February, 2017

Antibodies sourced from horses could be used as part of post-exposure treatment in the next Ebola outbreak, according to an international research team.


Accelerated HIV reduction in animal trial

07 February, 2017

Biotron has completed its HIV-1 animal trial of drug candidate BIT225, announcing positive results which caused the company's share prices to rise by almost 15%.


Fibrosis drug inspired by a shark antibody

01 February, 2017

Scientists from La Trobe University and biotechnology company AdAlta have created a humanised version of an antibody found in Wobbegong sharks.


Bioprinted kidneys

25 January, 2017 by Adam Florance

A collaborative effort between the Murdoch Childrens Research Institute, the Methuselah Foundation and Organovo has created a new hope for children suffering from kidney disease, with a pioneering use of 3D bioprinting technology.


The needle that makes brain surgery safer

23 January, 2017

Researchers have developed a brain biopsy needle with a tiny imaging probe inside, enabling surgeons to 'see' and avoid at-risk blood vessels as they insert the needle into patients' brains.


Lonza to acquire capsule manufacturer Capsugel

21 December, 2016

Lonza Group has entered into a definitive agreement to acquire drug capsule manufacturer Capsugel from the latter's parent organisation, KKR.


Add-on asthma treatments now available through the PBS

20 December, 2016

The Turnbull government will invest close to $130 million to give Australian asthma sufferers subsidised access to breakthrough medicines through the Pharmaceutical Benefits Scheme (PBS).


The golden touch: light-activated nanoparticles to treat macular degeneration

19 December, 2016

For sufferers of age-related macular degeneration (AMD), the only way to prevent severe vision loss is to endure regular injections into the back of the eye.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd